Asset Management One’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $28.8M | Buy |
54,796
+909
| +2% | +$510K | 0.07% | 229 |
|
|
2026
Q1 | $30.3M | Sell |
53,887
-781
| -1% | -$501K | 0.09% | 198 |
|
|
2025
Q4 | $37.6M | Sell |
54,668
-1,169
| -2% | -$796K | 0.1% | 162 |
|
|
2025
Q3 | $35.7M | Buy |
55,837
+217
| +0.4% | +$132K | 0.1% | 164 |
|
|
2025
Q2 | $29.8M | Sell |
55,620
-252
| -0.5% | -$121K | 0.09% | 191 |
|
|
2025
Q1 | $23.5M | Buy |
55,872
+3,028
| +6% | +$1.31M | 0.08% | 227 |
|
|
2024
Q4 | $21.9M | Buy |
52,844
+3,057
| +6% | +$1.34M | 0.08% | 235 |
|
|
2024
Q3 | $25.2M | Buy |
49,787
+707
| +1% | +$343K | 0.09% | 207 |
|
|
2024
Q2 | $23.9M | Buy |
49,080
+722
| +1% | +$362K | 0.09% | 195 |
|
|
2024
Q1 | $26.1M | Sell |
48,358
-8,114
| -14% | -$4.43M | 0.1% | 191 |
|
|
2023
Q4 | $31.5M | Buy |
56,472
+4,168
| +8% | +$1.96M | 0.13% | 154 |
|
|
2023
Q3 | $22.9M | Sell |
52,304
-4,431
| -8% | -$2.21M | 0.1% | 181 |
|
|
2023
Q2 | $28.5M | Buy |
56,735
+1,047
| +2% | +$502K | 0.12% | 160 |
|
|
2023
Q1 | $27.8M | Sell |
55,688
-134
| -0.2% | -$64.1K | 0.13% | 159 |
|
|
2022
Q4 | $22.9M | Sell |
55,822
-660
| -1% | -$256K | 0.11% | 190 |
|
|
2022
Q3 | $18.4M | Sell |
56,482
-4,179
| -7% | -$1.54M | 0.09% | 218 |
|
|
2022
Q2 | $21.3M | Buy |
60,661
+1,141
| +2% | +$465K | 0.1% | 200 |
|
|
2022
Q1 | $32.6M | Sell |
59,520
-4,353
| -7% | -$2.29M | 0.13% | 159 |
|
|
2021
Q4 | $41.9M | Buy |
63,873
+3,857
| +6% | +$2.42M | 0.15% | 134 |
|
|
2021
Q3 | $37.3M | Buy |
60,016
+839
| +1% | +$564K | 0.14% | 144 |
|
|
2021
Q2 | $37.4M | Buy |
59,177
+3,328
| +6% | +$1.84M | 0.14% | 147 |
|
|
2021
Q1 | $27.3M | Sell |
55,849
-4,685
| -8% | -$2.35M | 0.11% | 184 |
|
|
2020
Q4 | $29.9M | Buy |
60,534
+1,704
| +3% | +$762K | 0.12% | 168 |
|
|
2020
Q3 | $23.1M | Buy |
58,830
+2,180
| +4% | +$806K | 0.11% | 186 |
|
|
2020
Q2 | $18.7M | Buy |
56,650
+3,141
| +6% | +$909K | 0.09% | 216 |
|
|
2020
Q1 | $13M | Buy |
53,509
+175
| +0.3% | +$45.7K | 0.08% | 258 |
|
|
2019
Q4 | $13.9M | Sell |
53,334
-4,479
| -8% | -$1.18M | 0.06% | 321 |
|
|
2019
Q3 | $15.7M | Sell |
57,813
-5,632
| -9% | -$1.57M | 0.08% | 286 |
|
|
2019
Q2 | $17.5M | Sell |
63,445
-2,444
| -4% | -$602K | 0.09% | 254 |
|
|
2019
Q1 | $14.7M | Sell |
65,889
-86,081
| -57% | -$17.8M | 0.08% | 270 |
|
|
2018
Q4 | $28.3M | Buy |
151,970
+2,931
| +2% | +$601K | 0.07% | 303 |
|
|
2018
Q3 | $37.2M | Buy |
149,039
+6,392
| +4% | +$1.55M | 0.08% | 275 |
|
|
2018
Q2 | $31.1M | Buy |
142,647
+4,083
| +3% | +$841K | 0.07% | 312 |
|
|
2018
Q1 | $26.5M | Buy |
138,564
+343
| +0.2% | +$63.3K | 0.06% | 348 |
|
|
2017
Q4 | $21.6M | Sell |
138,221
-5,513
| -4% | -$868K | 0.05% | 413 |
|
|
2017
Q3 | $22.3M | Buy |
143,734
+2,977
| +2% | +$471K | 0.05% | 380 |
|
|
2017
Q2 | $22.7M | Buy |
140,757
+355
| +0.3% | +$57.7K | 0.06% | 362 |
|
|
2017
Q1 | $21.7M | Sell |
140,402
-10,723
| -7% | -$1.48M | 0.06% | 361 |
|
|
2016
Q4 | $17.7M | Buy |
151,125
+142,704
| +1,695% | +$16.3M | 0.05% | 419 |
|
|
2016
Q3 | $943K | Hold |
8,421
| – | – | 0.01% | 870 |
|
|
2016
Q2 | $769K | Buy |
+8,421
| New | +$723K | 0.01% | 933 |
|
|
2015
Q1 | – | Sell |
-34,070
| Closed | -$2.56M | – | 1354 |
|
|
2014
Q4 | $2.56M | Buy |
34,070
+17,380
| +104% | +$1.22M | 0.03% | 616 |
|
|
2014
Q3 | $997K | Buy |
+16,690
| New | +$1.06M | 0.01% | 825 |
|
Other funds holding IDXX
Asset Management One's IDXX Position: Q2 2026 in Review
Asset Management One increased its Idexx Laboratories (IDXX) stake by 1.7% in Q2 2026, buying an estimated $510K and bringing the position to 54,796 shares worth $28.8M. The position accounts for 0.07% of the portfolio, ranked #229.
Asset Management One first reported a position in IDXX in Q3 2014 and has held it in 43 quarters since. The position peaked at $41.9M in Q4 2021. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Asset Management One held 54,796 shares of Idexx Laboratories worth $28.8M as of Q2 2026.
- Asset Management One bought 909 Idexx Laboratories shares in Q2 2026, an estimated $510K.
- Idexx Laboratories made up 0.07% of Asset Management One's portfolio in Q2 2026, its #229 holding.
- Asset Management One first reported a position in Idexx Laboratories in Q3 2014 and has held it in 43 quarters since.
- Asset Management One's Idexx Laboratories position peaked at $41.9M in Q4 2021.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Asset Management One's 13F filing for Q2 2026, filed 28 Jul 2026.